LinkedIn (NYSE:LNKD): OTR Global says that LinkedIn is emerging as an important channel in the fragmented advertising market and notes that business-to-business advertiser use is growing, although it is still mostly discretionary due to a lack of scale.
Starbucks (NASDAQ:SBUX): Goldman Sachs has raised its price target on Starbucks to $84 from $76 based on a third-quarter report that the firm calls “impeccable.” The firm believes the company will build on strength by expanding further into food and leveraging the La Boulange platform. It has a Conviction Buy rating on the shares.
Gilead (NASDAQ:GILD): Stifel raised its price target on Gilead to $75 from $65 partly due to a reduction in the company’s competitive risk in the HCV space after the Food and Drug Administration placed a partial clinical hold on Vertex’s (NASDAQ:VRTX) HCV drug. The firm also cited Gilead’s potential filing of approval for idelalisib in INHL in the fourth quarter as a reason for the target increase, and it keeps a Buy rating on the shares.
Qlik Technologies (NASDAQ:QLIK): RBC Capital believes that Qlik reported good — but not great — results, while its guidance was conservative. The firm is upbeat about the company’s longer term outlook and it keeps an Outperform rating on the shares.